$61.16 -0.29 (%) Merck & Co Inc - NYSE

Jan. 29, 2015 | 12:45 PM

Partner Headlines

  1. Fast Money Halftime Report Final Trade From January 27

    Benzinga | Jan. 27, 2015 | 21:27PM EST
  2. White House Budget To Support Biotech Rally

    Benzinga | Jan. 27, 2015 | 16:00PM EST
  3. Putting Recent Layoff Reports in Economic Perspective

    FoxBusiness | Jan. 26, 2015 | 13:02PM EST
  4. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  5. The 5 Best Dow Stocks So Far In 2015

    Benzinga | Jan. 20, 2015 | 17:33PM EST
  6. World Economic Forum 2015 - What To Look Forward For

    GuruFocus | Jan. 18, 2015 | 07:40AM EST
  7. Barclays Issues 3 Upgrades, 1 Downgrade On Pharma Stocks

    Benzinga | Jan. 16, 2015 | 15:12PM EST
  8. Merck Takes A Step Forward In The World Of Medicine

    GuruFocus | Jan. 16, 2015 | 11:23AM EST
  9. Fast Money Halftime Report Final Trade From January 14

    Benzinga | Jan. 15, 2015 | 06:26AM EST
  10. Top Cybersecurity Stock Qualys Gets Support

    IBD | Jan. 13, 2015 | 17:42PM EST
  11. Stocks Rumble Ahead Despite Oil; Alaska Air, Celgene, Apple Jump

    IBD | Jan. 13, 2015 | 10:34AM EST
  12. Bristol-Myers Hits 14-Year High On Cancer Drug Trial

    IBD | Jan. 12, 2015 | 14:25PM EST
  13. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  14. Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014

    GuruFocus | Jan. 9, 2015 | 10:25AM EST
  15. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  16. Stock Indexes Gun For Best Pop In 3 Weeks; Monster Breaks Out

    IBD | Jan. 7, 2015 | 14:48PM EST
  17. Stocks Drop 1% In Rising Volume; Visa Falls 1%

    IBD | Jan. 5, 2015 | 10:33AM EST
  18. Ebola Drug Work Continues

    IBD | Dec. 26, 2014 | 18:22PM EST
  19. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  20. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  21. FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities

    Benzinga | Dec. 23, 2014 | 15:22PM EST
  22. Indexes Turn Mixed On Data; Celgene Dives

    IBD | Dec. 23, 2014 | 10:43AM EST
  23. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD | Dec. 22, 2014 | 10:34AM EST
  24. NewLink Genetics Surges 3% Following Ebola Contract News

    Benzinga | Dec. 22, 2014 | 09:32AM EST
  25. Tetraphase Jumps As 'Superbug' Drug Scores In Trial

    IBD | Dec. 18, 2014 | 11:54AM EST
  26. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus | Dec. 15, 2014 | 16:57PM EST
  27. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD | Dec. 11, 2014 | 14:25PM EST
  28. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  29. Celgene's Abraxane Succeeds In Early Breast Cancer

    IBD | Dec. 11, 2014 | 11:27AM EST
  30. Merck repurposes cancer drug

    IBD | Dec. 10, 2014 | 18:43PM EST
  31. Merck's Keytruda Might Treat Virulent Breast Cancer

    IBD | Dec. 10, 2014 | 11:04AM EST
  32. Data Investigating KEYTRUDA, Merck's Anti-PD-1 Therapy, In Patients With Advanced Triple-Negative Breast Cancer Presented At 2014 San Antonio Breast Cancer Symposium

    Benzinga | Dec. 10, 2014 | 08:34AM EST
  33. Merck-Cubist deal going ahead

    IBD | Dec. 9, 2014 | 18:42PM EST
  34. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
  35. Mizuho Securities Downgrades Cubist Pharmaceuticals Post Acquisition Announcement

    Benzinga | Dec. 9, 2014 | 12:14PM EST
  36. Merck-Cubist Deal Going Ahead Despite Patent Setback

    IBD | Dec. 9, 2014 | 11:27AM EST
  37. Hospira, Inc. Ticks Up On Favorable Patent Ruling vs. Cubist Pharmaceuticals Inc

    Benzinga | Dec. 9, 2014 | 11:09AM EST
  38. Pharmaceutical Giant Merck Buys Cubist Pharma

    GuruFocus | Dec. 9, 2014 | 11:04AM EST
  39. Stocks Swoon In Heavy Trade; Spirit Airlines Spirals Lower

    IBD | Dec. 9, 2014 | 10:38AM EST
  40. T Rowe Price's Top Stakes for the Third Quarter

    GuruFocus | Dec. 9, 2014 | 10:16AM EST
  41. Merck & Co. Under Pressure Following Patent Ruling

    Benzinga | Dec. 9, 2014 | 09:30AM EST
  42. Cellceutix Corp Shares Rise On Two Catalysts

    Benzinga | Dec. 9, 2014 | 09:28AM EST
  43. Merck Bets $9.5 Billion On Cubist's War On Superbugs

    IBD | Dec. 8, 2014 | 18:49PM EST
  44. Merck Buys Super Antibiotics

    IBD | Dec. 8, 2014 | 18:47PM EST
  45. Energy Leads Stock Sell-Off

    IBD | Dec. 8, 2014 | 18:47PM EST
  46. Benzinga's M&A Chatter for Monday December 8, 2014

    Benzinga | Dec. 8, 2014 | 18:27PM EST
  47. Making Money With Charles Payne: 12/8/14

    FoxBusiness | Dec. 8, 2014 | 18:00PM EST
  48. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  49. Mid-Afternoon Market Update: Dow Slides Over 100 Points; Oil Futures Down 4%

    Benzinga | Dec. 8, 2014 | 15:37PM EST
  50. Stocks Fall To Session Lows: GoPro Gives Up More Ground

    IBD | Dec. 8, 2014 | 13:25PM EST
Trading Center